» Articles » PMID: 31533332

Exosomal MiRNAs in Pediatric Cancers

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Sep 20
PMID 31533332
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) have generated great attention in oncology as they play a fundamental role in the regulation of gene expression and their aberrant expression is present in almost all types of tumors including pediatric ones. The discovery that miRNAs can be transported by exosomes, which are vesicles of 40-120 nm involved in cellular communication, that are produced by different cell types, and that are present in different biological fluids, has opened the possibility of using exosomal miRNAs as biomarkers. The possibility to diagnose and monitor the progression and response to drugs through molecules that can be easily isolated from biological fluids represents a particularly important aspect in the pediatric context where invasive techniques are often used. In recent years, the idea of liquid biopsy as well as studies on the possible role of exosomal miRNAs as biomarkers have developed greatly. In this review, we report an overview of all the evidences acquired in recent years on the identification of exosomal microRNAs with biomarker potential in pediatric cancers. We discuss the following herein: neuroblastoma, hepatoblastoma, sarcomas (osteosarcoma, Ewing's sarcoma and rhabdoid tumors, and non-rhabdomyosarcoma soft tissue sarcoma), brain tumors, lymphomas, and leukemias.

Citing Articles

Role of epigenetics in paediatric cancer pathogenesis & drug resistance.

Leung J, Chiu H, Taneja R Br J Cancer. 2025; .

PMID: 40055485 DOI: 10.1038/s41416-025-02961-2.


The Role of Chronic Inflammation in Pediatric Cancer.

Mella C, Tsarouhas P, Brockwell M, Ball H Cancers (Basel). 2025; 17(1.

PMID: 39796780 PMC: 11719864. DOI: 10.3390/cancers17010154.


Plasma-derived extracellular vesicles miR-335-5p as potential diagnostic biomarkers for fusion-positive rhabdomyosarcoma.

Di Paolo V, Paolini A, Galardi A, Gasparini P, De Cecco L, Colletti M J Exp Clin Cancer Res. 2024; 43(1):282.

PMID: 39385294 PMC: 11463097. DOI: 10.1186/s13046-024-03197-3.


The molecular conversations of sarcomas: exosomal non-coding RNAs in tumor's biology and their translational prospects.

Luongo M, Laurenziello P, Cesta G, Bochicchio A, Omer L, Falco G Mol Cancer. 2024; 23(1):172.

PMID: 39174949 PMC: 11340101. DOI: 10.1186/s12943-024-02083-y.


Tumor-exosomal miR-205-5p as a diagnostic biomarker for colorectal cancer.

Zhao Y, Zhao Y, Liu L, Li G, Wu Y, Cui Y Clin Transl Oncol. 2024; .

PMID: 39133387 DOI: 10.1007/s12094-024-03647-6.


References
1.
Macfarlane L, Murphy P . MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics. 2011; 11(7):537-61. PMC: 3048316. DOI: 10.2174/138920210793175895. View

2.
Sandlund J . Non-Hodgkin Lymphoma in Children. Curr Hematol Malig Rep. 2015; 10(3):237-43. DOI: 10.1007/s11899-015-0277-y. View

3.
Jo V, Fletcher C . WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology. 2014; 46(2):95-104. DOI: 10.1097/PAT.0000000000000050. View

4.
Gulino R, Forte S, Parenti R, Memeo L, Gulisano M . MicroRNA and pediatric tumors: Future perspectives. Acta Histochem. 2015; 117(4-5):339-54. DOI: 10.1016/j.acthis.2015.02.007. View

5.
Liu W, Chen S, Liu B . Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study. Pediatr Surg Int. 2016; 32(11):1059-1065. DOI: 10.1007/s00383-016-3960-8. View